Blue Water Life Science Advisors, LP Natera, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $114 Million
- Q3 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Natera, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 291,094 shares of NTRA stock, worth $50.7 Million. This represents 32.53% of its overall portfolio holdings.
Number of Shares
291,094
Previous 503,094
42.14%
Holding current value
$50.7 Million
Previous $54.5 Million
32.09%
% of portfolio
32.53%
Previous 52.98%
Shares
13 transactions
Others Institutions Holding NTRA
# of Institutions
547Shares Held
118MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.99 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.18 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$807 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$794 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$699 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.9B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...